Spleen Enlargement on Follow-Up Evaluation: A Noninvasive Predictor of Complications of Portal Hypertension in Cirrhosis  Annalisa Berzigotti, Paola Zappoli,

Slides:



Advertisements
Similar presentations
The Role of Psychosocial Care in Adapting to Health Care Reform
Advertisements

Abnormal Liver Tests and Fatty Liver on Ultrasound
Thrombocytopenia With Abnormal Liver Function Tests
Rates of and Reasons for Hospital Readmissions in Patients With Cirrhosis: A Multistate Population-based Cohort Study  Elliot B. Tapper, Brian Halbert,
Flavia D. Mendes, Ayako Suzuki, Schuyler O. Sanderson, Keith D
Millie D. Long, Bruce E. Sands 
Chronic Mesenteric Venous Thrombosis: Evaluation and Determinants of Survival During Long-Term Follow-up  David W. Orr, Phillip M. Harrison, John Devlin,
Rachel H. Westbrook, Andrew D. Yeoman, John G. O'Grady, Phil M
Spleen Enlargement on Follow-Up Evaluation: A Noninvasive Predictor of Complications of Portal Hypertension in Cirrhosis  Annalisa Berzigotti, Paola Zappoli,
CGH Receives High Impact Factor
Survival of Patients With Superficial Esophageal Adenocarcinoma After Endoscopic Treatment vs Surgery  Saowanee Ngamruengphong, Herbert C. Wolfsen, Michael.
Accuracy of Spleen Stiffness Measurement in Detection of Esophageal Varices in Patients With Chronic Liver Disease: Systematic Review and Meta-analysis 
Coordinating Care in Patients With Cirrhosis
Gauree Gupta, Ebbing Lautenbach, James D. Lewis 
Celiac Disease and Persistent Symptoms
A Shocking Cystory Clinical Gastroenterology and Hepatology
Todd H. Baron, MD, Thomas C. Smyrk, MD 
Portal Hypertensive Enteropathy in Small-Bowel Capsule Endoscopy
New Model for End Stage Liver Disease Improves Prognostic Capability After Transjugular Intrahepatic Portosystemic Shunt  Jennifer Guy, Ma Somsouk, Stephen.
Right Upper Quadrant Pain and a Normal Abdominal Ultrasound
Prevalence of Irritable Bowel Syndrome–type Symptoms in Patients With Celiac Disease: A Meta-analysis  Anita Sainsbury, David S. Sanders, Alexander C.
Liver Cirrhosis Is Associated With Venous Thromboembolism Among Hospitalized Patients in a Nationwide US Study  Harry Wu, Geoffrey C. Nguyen  Clinical.
Prevalence and Mechanisms of Malnutrition in Patients With Advanced Liver Disease, and Nutrition Management Strategies  Kally Cheung, Samuel S. Lee, Maitreyi.
Phillip S. Ge, MD, Bruce A. Runyon, MD 
Patients Whose First Episode of Bleeding Occurs While Taking a β-Blocker Have High Long-term Risks of Rebleeding and Death  Andrea Ribeiro de Souza, Vincenzo.
Stephen A. Harrison, MD, FACP  Clinical Gastroenterology and Hepatology 
Incidence and Prognosis of Different Types of Functional Renal Failure in Cirrhotic Patients With Ascites  Silvia Montoliu, Belén Ballesté, Ramon Planas,
Andree Koop, Michael J. Bartel, Dawn Francis 
Issue Highlights Clinical Gastroenterology and Hepatology
Talya Salz, Robert S. Sandler  Clinical Gastroenterology and Hepatology 
Proximal Esophageal Varices: A Rare Yet Treatable Cause of Hemorrhage
Jessica L. Mellinger, Michael L. Volk 
Issue Highlights Clinical Gastroenterology and Hepatology
AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review  Jean-Frederic Colombel,
Leon P. McLean, Jonathan S. Chun, Raymond K. Cross 
Abnormal Liver Tests and Fatty Liver on Ultrasound
Gastroenterology in a New Era of Accountability: Part 2
New Models of Gastroenterology Practice
Volume 144, Issue 1, Pages e1 (January 2013)
Issue Highlights Clinical Gastroenterology and Hepatology
David H. Bruining, William J. Sandborn 
Prednisolone and Budesonide for Short- and Long-Term Treatment of Microscopic Colitis: Systematic Review and Meta-analysis  Michael J. Stewart, Cynthia.
Peter Bytzer  Clinical Gastroenterology and Hepatology 
Patient-Reported Outcomes of Cirrhosis
Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome  Lilian Dindo, PhD  Clinical Gastroenterology.
Heiko Pohl, Douglas J. Robertson 
Accuracy of Spleen Stiffness Measurement in Detection of Esophageal Varices in Patients With Chronic Liver Disease: Systematic Review and Meta-analysis 
Issue Highlights Clinical Gastroenterology and Hepatology
Initiating Azathioprine for Crohn's Disease
Michael L. Volk, MD, MSc, AGAF 
Autoimmune Liver Disease Associated With Celiac Disease in Childhood: A Multicenter Study  Silvia Caprai, Pietro Vajro, Alessandro Ventura, Marco Sciveres,
Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet 
Thrombocytopenia With Abnormal Liver Function Tests
Immune Dysfunction and Infections in Patients With Cirrhosis
A 27-Year-Old Woman With Constipation: Diagnosis and Treatment
Patrick Yachimski, William P. Puricelli, Norman S. Nishioka 
Christopher Hung, Desmond Leddin 
Coagulation in Liver Disease: A Guide for the Clinician
Issue Highlights Clinical Gastroenterology and Hepatology
Risk of Pancreatitis in Patients With Celiac Disease: Is Autoimmune Pancreatitis a Biologically Plausible Mechanism?  John S. Leeds, David S. Sanders 
Issue Highlights Clinical Gastroenterology and Hepatology
Black and White Liver Clinical Gastroenterology and Hepatology
Rintaro Hashimoto, Akimichi Chonan 
Adverse Outcomes: Why Bad Things Happen to Good People
Medical Therapy for Refractory Pediatric Crohn’s Disease
Issue Highlights Clinical Gastroenterology and Hepatology
Sanjay K. Murthy, E. Jenny Heathcote, Geoffrey C. Nguyen 
Rintaro Hashimoto, Akimichi Chonan 
The Role of Psychosocial Care in Adapting to Health Care Reform
Choosing Wisely and the Perceived Drivers of Endoscopy Use
Presentation transcript:

Spleen Enlargement on Follow-Up Evaluation: A Noninvasive Predictor of Complications of Portal Hypertension in Cirrhosis  Annalisa Berzigotti, Paola Zappoli, Donatella Magalotti, Carolina Tiani, Valentina Rossi, Marco Zoli  Clinical Gastroenterology and Hepatology  Volume 6, Issue 10, Pages 1129-1134 (October 2008) DOI: 10.1016/j.cgh.2008.05.004 Copyright © 2008 AGA Institute Terms and Conditions

Figure 1 Spleen dimension on US follow-up evaluation in the studied population. As shown, spleen enlarged over time in cirrhotic patients (ANOVA, P < .0001). Clinical Gastroenterology and Hepatology 2008 6, 1129-1134DOI: (10.1016/j.cgh.2008.05.004) Copyright © 2008 AGA Institute Terms and Conditions

Figure 2 The actuarial probability of formation of varices at 5 years was higher in patients with increased spleen size at 1 year (grey line) vs those with stable spleen size (black line). Log-rank test, 8.47; P = .004. *Months of follow-up evaluation after the clinical, laboratory, and US assessment at 12 months. Clinical Gastroenterology and Hepatology 2008 6, 1129-1134DOI: (10.1016/j.cgh.2008.05.004) Copyright © 2008 AGA Institute Terms and Conditions

Figure 3 The actuarial probability of growth of varices at 5 years was higher in patients with increased spleen size at 1 year (grey line) vs those with stable spleen size (black line). Log-rank test, 3.42; P = .06. *Months of follow-up evaluation after the clinical, laboratory, and US assessment at 12 months. Clinical Gastroenterology and Hepatology 2008 6, 1129-1134DOI: (10.1016/j.cgh.2008.05.004) Copyright © 2008 AGA Institute Terms and Conditions

Figure 4 The actuarial probability of first clinical decompensation of cirrhosis at 5 years in patients with compensated disease at inclusion was higher in patients with increased spleen size at 1 year (grey line) vs patients with stable spleen size (black line) (log-rank test, 5.66; P = .017). *Months of follow-up evaluation after the clinical, laboratory, and US assessment at 12 months. Clinical Gastroenterology and Hepatology 2008 6, 1129-1134DOI: (10.1016/j.cgh.2008.05.004) Copyright © 2008 AGA Institute Terms and Conditions